Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1972 1
1975 1
1976 1
1978 1
1979 1
1983 1
1984 1
1985 2
1986 2
1987 5
1988 4
1989 9
1990 4
1991 6
1992 9
1993 3
1994 2
1995 4
1997 3
1998 3
1999 5
2000 2
2001 2
2002 1
2005 1
2006 2
2007 3
2008 1
2009 3
2010 8
2011 5
2012 6
2013 2
2014 5
2015 1
2016 5
2017 4
2018 4
2019 3
2020 2
2022 2
2023 4
2024 4
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy.
Hosking MP, Shirinbak S, Omilusik K, Chandra S, Kaneko MK, Gentile A, Yamamoto S, Shrestha B, Grant J, Boyett M, Cardenas D, Keegan H, Ibitokou S, Pavon C, Mizoguchi T, Ihara T, Nakayama D, Abujarour R, Lee TT, Clarke R, Goodridge J, Peralta E, Maeda T, Takagi J, Arimori T, Kato Y, Valamehr B. Hosking MP, et al. Cell Stem Cell. 2025 Jul 3;32(7):1087-1101.e4. doi: 10.1016/j.stem.2025.05.007. Epub 2025 Jun 4. Cell Stem Cell. 2025. PMID: 40472844
A novel CD3ε fusion receptor allows T cell engager use in TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape.
Lu D, Chu HY, Park S, Landon M, Tsuda M, Avramis E, Dege C, Dailey T, Pan Y, Hanok SK, Denholtz M, Abujarour R, Lee T, Goulding J, Hosking M, Goodridge J, Peralta E, Valamehr B. Lu D, et al. Among authors: hosking m. Mol Ther. 2025 Sep 3;33(9):4570-4583. doi: 10.1016/j.ymthe.2025.05.030. Epub 2025 May 28. Mol Ther. 2025. PMID: 40443031
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma.
Dixon KJ, Snyder KM, Khaw M, Hullsiek R, Davis ZB, Matson AW, Shirinbak S, Hancock B, Bjordahl R, Hosking M, Miller JS, Valamehr B, Wu J, Walcheck B. Dixon KJ, et al. Among authors: hosking m. Front Immunol. 2024 Jul 19;15:1407567. doi: 10.3389/fimmu.2024.1407567. eCollection 2024. Front Immunol. 2024. PMID: 39100677 Free PMC article.
iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors.
Yang BH, Gutierrez A, Liao A, Shirinbak S, Gaertner B, Pribadi M, Chu HY, Tsai PF, Lin YE, Gonzalez D, Yeh WI, Chang CW, Bjordahl R, Lee T, Hosking M, Peralta E, Valamehr B. Yang BH, et al. Among authors: hosking m. Cell Rep Med. 2025 Jul 15;6(7):102195. doi: 10.1016/j.xcrm.2025.102195. Epub 2025 Jun 19. Cell Rep Med. 2025. PMID: 40541190 Free PMC article.
Salt and hypertension.
Hosking M. Hosking M. Med J Aust. 1979 Oct 6;2(7):351-2. doi: 10.5694/j.1326-5377.1979.tb104151.x. Med J Aust. 1979. PMID: 514183 No abstract available.
138 results